Ward S J, Douce G, Dougan G, Wren B W
Microbial Pathogenicity Research Group, Department of Microbiology, St. Bartholomew's and the Royal London School of Medicine and Dentistry, West Smithfield, London ECIA 7BE, United Kingdom.
Infect Immun. 1999 Oct;67(10):5124-32. doi: 10.1128/IAI.67.10.5124-5132.1999.
Fourteen of the 38 C-terminal repeats from Clostridium difficile toxin A (14CDTA) were cloned and expressed either with an N-terminal polyhistidine tag (14CDTA-HIS) or fused to the nontoxic binding domain from tetanus toxin (14CDTA-TETC). The recombinant proteins were successfully purified by bovine thyroglobulin affinity chromatography. Both C. difficile toxin A fusion proteins bound to known toxin A ligands present on the surface of rabbit erythrocytes. Intranasal immunization of BALB/c mice with three separate 10-microg doses of 14CDTA-HIS or -TETC generated significant levels of anti-toxin A serum antibodies compared to control animals. The coadministration of the mucosal adjuvant heat labile toxin (LT) from Escherichia coli (1 microg) significantly increased the anti-toxin A response in the serum and at the mucosal surface. Importantly, the local and systemic antibodies generated neutralized toxin A cytotoxicity. Impressive systemic and mucosal anti-toxin A responses were also seen following coadministration of 14CDTA-TETC with LTR72, an LT derivative with reduced toxicity which shows potential as a mucosal adjuvant for humans.
艰难梭菌毒素A的38个C端重复序列中的14个(14CDTA)被克隆并表达,其要么带有N端多聚组氨酸标签(14CDTA-HIS),要么与破伤风毒素的无毒结合域融合(14CDTA-TETC)。重组蛋白通过牛甲状腺球蛋白亲和层析成功纯化。两种艰难梭菌毒素A融合蛋白均与兔红细胞表面存在的已知毒素A配体结合。与对照动物相比,用三个单独的10微克剂量的14CDTA-HIS或-TETC对BALB/c小鼠进行鼻内免疫产生了显著水平的抗毒素A血清抗体。同时给予来自大肠杆菌的黏膜佐剂热不稳定毒素(LT,1微克)可显著增强血清和黏膜表面的抗毒素A反应。重要的是,产生的局部和全身抗体中和了毒素A的细胞毒性。在将14CDTA-TETC与LTR72(一种毒性降低的LT衍生物,显示出作为人类黏膜佐剂的潜力)同时给药后,也观察到了令人印象深刻的全身和黏膜抗毒素A反应。